维普中文期刊产品整合服务
50篇 您的检索式:作者名="Assaraf YG"
    题名 作者 年代 出处 被引量
1Arabinogalactan folic acid drug conjugate for targeted delivery and targe- tactivated release of anticaneer drugs to folate receptor- overexpressing cells显示文摘Pinhassi RI Assaraf YG Farber S 2010Biomacromolecules2010,11,1:1
2Disruption of Pglycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope显示文摘Hans-Cohen M Assaraf YG Binyamin L 2004Int J Cancer2004,109,5:1
3Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mecha-nism of adaptation to short-term folate deprivation 显示文摘Ifergan I Jansen G Assaraf YG 2005Mol Phamacol2005,67,4:1
4Methotrexate nor- malizes up-regulated folate pathway genes in rheumatoid arthritis显示文摘Blits M Jansen G Assaraf YG 2013Arthritis Rheum2013,65,11:1
5Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis显示文摘Eytan GD Regev R Assaraf YG 1996J Biol Chem1996,271,6:1
6Antifolates in cancer therapy : structure, activity and mechanisms of drug resistance显示文摘Gonen N Assaraf YG 2012Drug Resist Up- dat2012,15,4:1
7Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracel- lular vesicles and overcomes muhidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Biochem Pharmacol2012,83,10:1
8Inhibition of the PI3K- Akt signaling pathway disrupts ABCG2-rich extracellular vesi- cles and overcomes muhidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Biochem Pharmacol2012,83,10:1
9Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance显示文摘Gonen N Assaraf YG 2012Drug Resist Updat2012,15,4:1
10Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Bioehem Pharmacol2012,83,10:1
11Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope显示文摘Haus-Cohen M Assaraf YG Binyamin L 2004Int J Cancer2004,109,5:1
12Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity显示文摘Shapira A Markman G Assaraf YG 2010Nanomedicine2010,6,4:1
13Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation 显示文摘IFERGAN I JANSEN G ASSARAF YG 2005Mol Pharmacol2005,67,4:1
14Molecular basis of antifolate resistance 显示文摘Assaraf YG 2007Cancer Metastasis Rev2007,26,1:1
15Differential reversal of lipophilic antifolate resistance in mammalian cells with modulations of the multidrug resistance phenotype 显示文摘 Borgnia MJ 1993Anti-cancerDrugs1993,4,3:1
16Molecular basis of bortezomib resistance:proteasome subunit betaS (PSMB5)gene mutation and overexpression of PSMB5 protein显示文摘Oerlemans R Franke NE Assaraf YG 0,,:1
17The role of muitidrug resistance efflux transporters in antifolate resistance and folate homeostasis 显示文摘Assaraf YG 2006Drug Resist Updat2006,9,45:1
18Disruption of P-glycoprotein anticancer drug flux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope 显示文摘Haus-cohen M Assaraf YG Binyamin L 2004Int J Cancer2004,109,5:1
19Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein显示文摘Oerlemans R Franke NE Assaraf YG 2008Blood2008,112,6:1
20Inactivating PSMB5 mutations and P- glycoprotein (muhidrug resistance- associated protein/ATP- binding cassette B1 ) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno) proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis显示文摘VERBRUGGE SE ASSARAF YG DIJKMANS BA 2012J Pharmacol Exp Ther2012,341,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费